| |
| |
|
| Insider
Information: |
Kakkis Emil D |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
603,534 |
|
|
Indirect Shares
|
2,268,639 |
|
|
| Direct
Value |
$27,122,647 |
|
|
|
Indirect Value
|
$95,205,536 |
|
|
| Total
Shares |
2,872,173 |
|
|
| Total
Value |
$122,328,183 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Chief Medical Officer |
2009-03-02 |
39,621 |
2009-03-02 |
4,654 |
Premium* |
|
|
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
563,913 |
2024-03-01 |
2,263,985 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-11-03 |
4 |
OE |
$18.11 |
$307,938 |
D/D |
17,000 |
114,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-11-03 |
4 |
OE |
$6.13 |
$98,080 |
D/D |
16,000 |
131,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2008-11-25 |
4 |
S |
$15.98 |
$1,198,740 |
D/D |
(75,000) |
39,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
CHIEF MEDICAL OFFICER |
• – – |
2008-12-01 |
4 |
OE |
$6.13 |
$104,210 |
D/D |
17,000 |
56,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
CHIEF MEDICAL OFFICER |
• – – |
2008-12-01 |
4 |
AS |
$15.87 |
$269,790 |
D/D |
(17,000) |
39,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical officer |
• – – |
2009-01-02 |
4 |
OE |
$6.13 |
$107,335 |
D/D |
17,000 |
56,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical officer |
• – – |
2009-01-02 |
4 |
AS |
$17.57 |
$298,690 |
D/D |
(17,000) |
39,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2009-02-03 |
4 |
AS |
$19.14 |
$325,373 |
D/D |
(17,000) |
39,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2009-02-03 |
4 |
OE |
$6.43 |
$109,310 |
D/D |
17,000 |
56,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2009-03-02 |
4 |
OE |
$6.43 |
$50,778 |
D/D |
7,897 |
47,518 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Medical Officer |
• – – |
2009-03-02 |
4 |
AS |
$11.70 |
$92,396 |
D/D |
(7,897) |
39,621 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• – – |
2005-10-31 |
4 |
A |
$3.43 |
$8,832 |
D/D |
2,572 |
29,574 |
|
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • • |
2014-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
624,240 |
624,240 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,400 |
635,640 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-10-30 |
4 |
AS |
$98.63 |
$1,991,407 |
D/D |
(20,000) |
615,640 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-11-30 |
4 |
AS |
$96.46 |
$1,965,427 |
D/D |
(20,000) |
595,640 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-12-18 |
5 |
GD |
$0.00 |
$0 |
D/D |
18,121 |
557,519 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-12-30 |
4 |
AS |
$113.30 |
$1,666,198 |
D/D |
(14,502) |
581,138 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2015-12-31 |
4 |
AS |
$112.91 |
$624,294 |
D/D |
(5,498) |
575,640 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-04-15 |
4 |
AS |
$69.46 |
$1,406,554 |
D/D |
(20,000) |
537,519 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-05-16 |
4 |
AS |
$59.37 |
$1,199,095 |
D/D |
(20,000) |
517,519 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-05-21 |
4 |
D |
$64.01 |
$68,619 |
D/D |
(1,072) |
516,447 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,700 |
527,147 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-07-15 |
4 |
AS |
$50.61 |
$1,016,909 |
D/D |
(20,000) |
507,147 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
President & CEO |
• • – |
2016-08-15 |
4 |
AS |
$67.39 |
$1,352,251 |
D/D |
(20,000) |
487,147 |
0 |
- |
|
106 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
